Sarepta Therapeutics (SRPT)
(Delayed Data from NSDQ)
$128.77 USD
+1.38 (1.08%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $128.69 -0.08 (-0.06%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth D Momentum C VGM
Earnings News For SRPT
-
Sarepta Therapeutics (SRPT) Up 1.2% Since Last Earnings Report: Can It Continue?
-
Sarepta (SRPT) Q4 Earnings Beat Estimates, Revenues Up Y/Y
-
Sarepta Therapeutics: Q4 Earnings Snapshot
-
Sarepta (SRPT) to Report Q4 Earnings: Will It Beat Estimates?
-
Sarepta Therapeutics (SRPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
-
Sarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2023 Net Product Revenue
-
Sarepta Therapeutics (SRPT) Up 4.5% Since Last Earnings Report: Can It Continue?
-
Sarepta (SRPT) Q3 Loss Narrower Than Expected, Sales Beat
-
Sarepta Therapeutics: Q3 Earnings Snapshot
-
Sarepta Therapeutics (SRPT) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Sarepta Therapeutics (SRPT) Up 12.7% Since Last Earnings Report: Can It Continue?
-
Sarepta (SRPT) Q2 Loss Narrower Than Expected, Sales Miss
-
Sarepta Therapeutics (SRPT) Reports Q2 Loss, Misses Revenue Estimates
-
Sarepta Therapeutics: Q2 Earnings Snapshot
-
Sarepta Therapeutics (SRPT) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
-
Why Is Sarepta Therapeutics (SRPT) Down 1.5% Since Last Earnings Report?
-
Sarepta (SRPT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
-
Sarepta Therapeutics (SRPT) Reports Q1 Loss, Tops Revenue Estimates
-
Sarepta Therapeutics: Q1 Earnings Snapshot
-
Sarepta Therapeutics (SRPT) Down 6.2% Since Last Earnings Report: Can It Rebound?
-
Sarepta (SRPT) Q4 Earnings & Sales Beat Estimates, Stock Up
-
Sarepta Therapeutics: Q4 Earnings Snapshot
-
Sarepta Therapeutics (SRPT) Reports Q4 Loss, Tops Revenue Estimates
-
Sarepta Therapeutics Reports Preliminary* Fourth Quarter and Full-Year 2022 Net Product Revenues
-
Sarepta Therapeutics (SRPT) Up 17.1% Since Last Earnings Report: Can It Continue?